AVN 65.45 Increased By ▲ 0.50 (0.77%)
BAFL 30.65 Decreased By ▼ -0.86 (-2.73%)
BOP 4.83 Increased By ▲ 0.04 (0.84%)
CNERGY 3.72 Decreased By ▼ -0.12 (-3.13%)
DFML 14.26 Decreased By ▼ -0.15 (-1.04%)
DGKC 41.06 Decreased By ▼ -0.54 (-1.3%)
EPCL 46.56 Decreased By ▼ -0.14 (-0.3%)
FCCL 11.35 Increased By ▲ 0.06 (0.53%)
FFL 5.03 Decreased By ▼ -0.02 (-0.4%)
FLYNG 5.78 Decreased By ▼ -0.04 (-0.69%)
GGL 10.28 Decreased By ▼ -0.17 (-1.63%)
HUBC 67.03 Increased By ▲ 1.39 (2.12%)
HUMNL 5.68 Increased By ▲ 0.02 (0.35%)
KAPCO 27.85 Increased By ▲ 0.10 (0.36%)
KEL 2.19 Increased By ▲ 0.04 (1.86%)
LOTCHEM 24.83 Increased By ▲ 0.48 (1.97%)
MLCF 21.37 Decreased By ▼ -0.11 (-0.51%)
NETSOL 84.20 Decreased By ▼ -0.59 (-0.7%)
OGDC 85.94 Decreased By ▼ -1.31 (-1.5%)
PAEL 11.01 Increased By ▲ 0.03 (0.27%)
PIBTL 4.17 Decreased By ▼ -0.05 (-1.18%)
PPL 74.56 Decreased By ▼ -1.14 (-1.51%)
PRL 13.40 Decreased By ▼ -0.25 (-1.83%)
SILK 0.92 Increased By ▲ 0.03 (3.37%)
SNGP 40.44 Decreased By ▼ -0.89 (-2.15%)
TELE 5.86 Increased By ▲ 0.01 (0.17%)
TPLP 15.42 Decreased By ▼ -0.22 (-1.41%)
TRG 111.63 Decreased By ▼ -0.07 (-0.06%)
UNITY 13.76 Decreased By ▼ -0.22 (-1.57%)
WTL 1.14 Decreased By ▼ -0.02 (-1.72%)
BR100 4,037 Decreased By -26.9 (-0.66%)
BR30 14,412 Decreased By -56.6 (-0.39%)
KSE100 40,471 Decreased By -262.4 (-0.64%)
KSE30 15,163 Decreased By -67.2 (-0.44%)
World

Novavax hopes to file for US vaccine approval in 2nd quarter of 2021

  • That will likely be in the second quarter of 2021, depending on the virulence of the Covid-19 epidemic in the two countries, according to the Novavax statement.
Published March 2, 2021
Follow us

WASHINGTON: US biotech company Novavax said Monday it hopes to file for British approval of its Covid-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States.

The company has no assurance that US authorities will agree to consider the request, which currently is based on results from Phase 3 clinical trials led in the Britain. Similar trials are still ongoing in the United States.

The data will hopefully be presented to the British health regulator (MHRA) "by early second quarter 2021," Novavax said in a statement, on the occasion of the publication of its quarterly results.

There is an "ongoing dialogue" with the US Food and Drug Administration (FDA), "with potential for EUA (emergency use authorization) filing in the second quarter of 2021," the statement said.

"Our hope and expectation is that the FDA will agree to review the UK data as part of the EUA filing in the US," Novavax CEO Stanley Erck told CBS, though he acknowledged there was no assurance that the FDA will do so.

Erck added that Novavax has "a different dataset than AstraZeneca," which developed a vaccine with Oxford University.

US health authorities are waiting for the results of trials led in the United States before approving the AstraZeneca jab, even though the drug is already approved in Europe.

If the FDA refuses to study Novavax's British data, the approval procedure will be postponed until the results of its trials in the United States and Mexico, for which 30,000 volunteers have been inoculated, are known.

That will likely be in the second quarter of 2021, depending on the virulence of the Covid-19 epidemic in the two countries, according to the Novavax statement.

The clinical trials conducted in Britain involved 15,000 people and showed 89.3 percent efficacy for the vaccine, Novavax announced at the end of January.

The Novavax vaccine was 95.6 percent effective against the original Covid-19 strain and 85.6 percent effective against the British variant.

The British government has secured an order for 60 million doses of the Novavax jab.

Comments

Comments are closed.

Novavax hopes to file for US vaccine approval in 2nd quarter of 2021

Dar hits out at Imran Khan’s ‘irresponsible tweet’ about current govt

Islamabad court sends Sheikh Rashid on 14-day judicial remand

Analyst fears further rupee decline in coming days

Alluding to PTI, PM asks where Rs417bn spent?

Govt says ‘will have to’ agree to IMF conditions

Wikipedia asks Pakistan to restore access to its service

Pakistan to appeal to Taliban leader after terrorism surges

PTI chief won’t attend APC: Umar

US allows seized Russian money to go to Ukraine aid: report

Industry yet to export any amount of sugar